Amazon Supplement Listing Deactivated: The Claim Test Comes Before the TIC Test

When an Amazon supplement listing goes inactive, most sellers assume one problem: a missing document, or a word an algorithm disliked. In the US, Amazon actually runs two independent gates. One is verification — facility, testing, and label documentation. The other is claims — what the detail page says the product does. Passing one gate does not clear the other, and that is why appeals often fail even when the seller fixed something real.

This article separates the two paths, quotes the line federal rules draw between a structure/function claim and a disease claim, and lists the surfaces sellers forget to check. Sources were opened on 2026-10-22. Amazon policy and FDA guidance change; re-check the linked originals before you submit.

Start with the notice, not the copy

Two different messages can look like the same deactivation in Seller Central.

• A compliance request points you to Manage Your Compliance, names a due date, and asks you to initiate testing with a third-party Testing, Inspection, and Certification (TIC) organization. This is the verification gate.
• A policy notification says the listing was identified as a supplement, consumable, cosmetic, or topical product that makes prohibited disease claims, or asks you to apply for approval to sell supplements. This is the claims gate — even when your product is not a supplement.

The distinction matters because the evidence that clears each gate is different. A lab report cannot authorize a disease claim, and deleting a sentence cannot produce a lab report.

Gate 1: the supplement verification request

Amazon announced the current verification model in April 2024: “Effective April 2, 2024, dietary supplement products need to be verified through a third-party Testing, Inspection, and Certification (TIC) organization.” The same announcement says the Manage Your Compliance dashboard shows which listings need action and their due dates, and that listings may be removed if they are not confirmed as compliant by that date.

Amazon's seller-facing guidance in September 2025 describes annual verification and what the testing is meant to establish. According to that guidance, testing must be conducted by ISO 17025 accredited labs, GMP certification must be current and from an accredited third party, and the verification covers five points:

1. The product is manufactured in FDA-compliant facilities following Current Good Manufacturing Practice (cGMP).
2. It does not contain harmful contaminants.
3. It includes all ingredients listed on the label.
4. It is free from undeclared pharmaceutical ingredients.
5. It meets FDA labeling guidelines.

That is a product-and-facility check. It is not a review of your promotional intent, and it does not pre-approve a sentence. A supplement can pass every one of those five points and still be deactivated for a claim in the title, a bullet, an image, or a backend search term.

One practical consequence: if the notice points to Manage Your Compliance, do not spend the week rewriting copy first. Initiate the test, then use the waiting time to audit claims. The two workstreams are parallel, not sequential.

Gate 2: prohibited disease claims on the detail page

Amazon's supplement rules are unusually specific, and they are stated in the seller forums by Amazon staff. In a public reply to a seller whose listings were deactivated, an Amazon moderator listed what a supplement detail page must contain and what it must not say. The prohibitions include:

• Do not state that the product cures, mitigates, treats, or prevents a disease in humans, “unless that statement is approved by the FDA.”
• Do not include disease names in the keywords.
• Do not claim the product has the same effects as controlled substances or prescription drugs.
• Do not call the product an alternative to a prescription drug, or say it is just as effective.
• Do not claim an effect similar to an anabolic steroid, such as “Legal Steroids.”
• Do not say the supplement is “FDA approved.”
• Do not use the FDA logo in listing images.

The same reply lists the required detail-page elements: the supplement name, the ingredient list including an image of the label's ingredient list, the total quantity, and a direct image of the entire label showing the facts panel, ingredients, certification logos, identity statement, instructions, and warnings, plus the brand owner or manufacturer's name and contact information. The label itself must be in English and carry a Supplement Facts panel, an ingredient list, and the manufacturer, packer, or distributor's name and address.

Notice what is missing from that list: intent. The reviewer is reading what the page asserts, not what you meant. That is also why a product that is not a supplement can land here. In another public thread, a seller reported nearly 50 inactive ASINs and said the products were not supplements. An Amazon moderator reviewed the account and said about six listings had been deactivated for being “identified as a supplement, consumable product, cosmetic, or topical product that makes prohibited disease claims.” The flag followed the claim, not the catalog category.

Where FDA draws the line Amazon is enforcing

Amazon's wording tracks federal labeling law, so the federal line is the useful one to learn. FDA describes structure/function claims as statements that “describe the role of a nutrient or dietary ingredient intended to affect the normal structure or function of the human body,” or that characterize the mechanism by which it acts. These claims are not pre-approved, but the manufacturer must have substantiation that the claim is truthful and not misleading, must notify FDA no later than 30 days after first marketing the product with the claim, and must include a disclaimer.

The disclaimer text is fixed. Under 21 CFR 101.93(c), a single claim must be accompanied by: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” The regulation requires the disclaimer to be placed adjacent to the statement, or linked to it with a symbol, and to appear in boldface type no smaller than one-sixteenth inch. Where there are multiple statements, each must carry the disclaimer or a plural version must be linked to all of them.

Then comes the fork. Under 21 CFR 101.93(f), if a product marketed as a dietary supplement bears a disease claim, “the product will be subject to regulation as a drug” unless the claim is an authorized health claim. FDA's criteria for a disease claim are broad and contextual. A statement can be a disease claim if it claims, explicitly or implicitly, an effect on a specific disease or class of diseases, an effect on characteristic signs or symptoms, or an effect through the product's name, a cited publication, or pictures, vignettes, or symbols.

That last set of triggers is where most self-inflicted listing problems live. A claim does not have to use the word “cure” to be read as a disease claim.

These examples are hypothetical illustrations of the distinction, not approved wording and not legal advice. The same sentence can move categories depending on the surrounding page, the product name, and the images next to it.

Why the two fixes are not interchangeable

Three failure patterns account for most of the confusion.

Pattern 1: documents pending, claims clean. The seller rewrites every bullet, resubmits, and stays inactive. Nothing on the page was the problem; the compliance dashboard is still waiting for a TIC result. Fix: initiate or complete verification, and keep the claim edits as a separate change.

Pattern 2: verification passed, one disease claim left. The lab report confirms the product, but the A+ module still says the supplement “helps fight disease” or a backend search term contains a condition name. Fix: audit every surface, including the ones that are not visible in the main bullet block.

Pattern 3: not a supplement, flagged anyway. A topical, a device, or a consumable gets pulled because the copy implies a disease benefit. Fix: treat the notice as a claims notice, not a category dispute, and remove the disease implication before arguing about classification.

In the public threads where listings were reinstated, an Amazon employee escalated the existing case, and reinstatement followed. Reopening the same content gives a reviewer nothing new to evaluate.

The surfaces sellers forget

A claim audit that stops at the five bullets will miss most of the risk. Check, in this order:

1. Title and product name. A condition in the name is a claim before the first bullet.
2. Bullets and description. Look for disease names, symptom language, and drug comparisons.
3. A+ content and brand story. These modules are part of the detail page and are easy to leave untouched during a rewrite.
4. Images. Infographics, symptom checklists, body diagrams, before/after values, and badges. A claim inside an image is still a claim; an image checker does not establish that the wording inside it is allowed.
5. Backend search terms. Amazon's guidance says disease names must not appear in keywords simply because they are not visible on the page.
6. Video and variation names. Spoken claims and variation labels are read the same way as on-page text.
7. The label itself. The label must match what the detail page and the test report say. A supplement whose label carries a disease claim is a labeling problem independent of Amazon.

What a text checker can and cannot do

A claim checker is useful for the mechanical part: finding disease vocabulary, drug-equivalence phrasing, “FDA approved,” missing disclaimers, and condition names in backend terms. It can compare a draft against the wording FDA publishes and flag the sentences a reviewer is most likely to read as disease claims.

It cannot verify substantiation, approve a claim, clear a TIC requirement, restore an account, or decide whether a specific structure/function claim is truthful for your formulation. Those depend on your evidence, your facility, and the platform's review. The honest division of labor is: the checker finds the sentence, your substantiation file defends it, and the TIC provider proves the product.

Frequently asked questions

Does passing the TIC test mean my supplement claims are approved?

No. The TIC process verifies the product, the facility, and label-related requirements. It does not approve promotional claims. Amazon's detail-page rules on disease claims apply separately, and FDA's claim rules apply regardless of what Amazon reviews.

Can I keep a structure/function claim without the FDA disclaimer?

Not on labeling that bears the claim. 21 CFR 101.93 requires the disclaimer to accompany the statement, in boldface and at the specified size, and to be adjacent or symbol-linked. If you keep the claim, keep the exact disclaimer with it rather than hiding it in a separate tab or an image.

My product is not a supplement. Why was it flagged as one?

Because the notice can follow a prohibited disease claim rather than the product category. Amazon staff have described deactivations for products “identified as a supplement, consumable product, cosmetic, or topical product that makes prohibited disease claims.” Audit the claim first, then address classification.

Does removing the disease claim clear a listing that is waiting on verification?

No. The compliance dashboard is tracking a document requirement. Removing a sentence does not satisfy it. Check which notice you received and clear that gate.

Can I say “FDA approved” if my facility is FDA registered?

No. Amazon's supplement rules prohibit saying a supplement is “FDA approved” or using the FDA logo in listing images. FDA also states plainly that it does not approve dietary supplements, and that registration of a facility does not denote approval.

Sources

• Amazon Seller Forums, News_Amazon, Changes to dietary supplements policy (April 2, 2024).
• Amazon Seller Forums, Kai_Amazon, Your Complete Supplements Compliance Guide (September 29, 2025).
• Amazon Seller Forums, Amazon moderator reply in Listing made inactive (supplement detail-page requirements and prohibited claims).
• U.S. Food and Drug Administration, Structure/Function Claims (content current as of March 28, 2024).
• Electronic Code of Federal Regulations, 21 CFR 101.93, Certain types of statements for dietary supplements.
• U.S. Food and Drug Administration, Is It Really 'FDA Approved'? (content current as of May 4, 2026).

For the adjacent problem on Amazon — pesticide and antimicrobial claims, where the product may need registration rather than a rewrite — see the Amazon pesticide claims guide. For the TikTok Shop version of the supplement gate, see TikTok Shop supplement requirements. To review a draft before it goes back into the case, use the supplement claim checker, and see Amazon and online store compliance checks for the wider workflow.